This Week

Richard Levick in WSJ

LEVICK |

Richard Levick in WSJ

Richard Levick was recently quoted in the Wall Street Journal on Mylan’s handling of the EpiPen crisis:

“It™’s not good when a corporate crisis gets its own hashtag and thousands of people begin using it. It™’s even worse when that hashtag ends in ‘gate.’ Yet Mylan™’s handling of its EpiPen pricing issue–#Epigate as it was tagged by one parent/activist–is hardly scandalous. In truth, once it became a news story three days after #Epigate was coined, Mylan deserves reasonably high marks for its response.  Its messaging and strategy were solid. It offered a discounted purchasing plan. It took the dramatic step of developing a generic alternative to make EpiPen more affordable. Its chief executive assumed public responsibility and made herself accessible to the media.”

 

LEVICK |

Richard Levick in WSJ

Richard Levick was recently quoted in the Wall Street Journal on Mylan’s handling of the EpiPen crisis:

“It™’s not good when a corporate crisis gets its own hashtag and thousands of people begin using it. It™’s even worse when that hashtag ends in ‘gate.’ Yet Mylan™’s handling of its EpiPen pricing issue–#Epigate as it was tagged by one parent/activist–is hardly scandalous. In truth, once it became a news story three days after #Epigate was coined, Mylan deserves reasonably high marks for its response.  Its messaging and strategy were solid. It offered a discounted purchasing plan. It took the dramatic step of developing a generic alternative to make EpiPen more affordable. Its chief executive assumed public responsibility and made herself accessible to the media.”

 

  • [blog_shorcode_show]